Self-Designed Ningxin Anshen Formula for Treatment of Post-ischemic Stroke Insomnia: A Randomized Controlled Trial

Self-Designed Ningxin Anshen Formula for Treatment of Post-ischemic Stroke Insomnia: A Randomized Controlled Trial

This study aimed to assess the efficacy and safety of self-designed Ningxin Anshen (NXAS) Formula for post-ischemic stroke insomnia of blood-deficient and liver-heat syndrome. Ninety patients were randomized into NXAS group, Placebo group and Zopiclone group. Patients in the NXAS group, Placebo grou...

Full description

Bibliographic Details
Main Authors: Ning Dai, Yuanyuan Li, Jing Sun, Feng Li, Hang Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Neurology
Subjects:
Ningxin Anshen Formula
post-stroke insomnia
Pittsburgh Sleep Quality Index
Insomnia Severity Index
randomized controlled trial
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.537402/full

Similar Items

Similar Items